Search | ARVO Journals

Showing 1 – 20 of 1727

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina September 2023

Choroidal Vortex Vein Drainage System in Central Serous Chorioretinopathy Using Ultra-Widefield Optical Coherence Tomography Angiography

PDF

Zhonghua Luo; Yue Xu; Kun Xu; Matthew Fan; Ching-Kit Tsui; Xi Lu; Benjuan Wu; Xinyu Zhao; Xiaoyu Tang; Peiqi Wu; Kaixuan Cui; Shanshan Yu; Xiaoling Liang
TAGS: angiogram, central serous chorioretinopathy, discharge, body substance, drainage procedure, optical coherence tomography, eye, choroid
Trans. Vis. Sci. Tech.. 2023; 12(9):17. https://doi.org/10.1167/tvst.12.9.17

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Choroidal Angiographic Feature Associated with Persistent Subretinal Fluid in Central Serous Chorioretinopathy

Takahiro Kogo; Yuki Muraoka; Masaharu Ishikura; Naomi Nishigori; Naoko Ueda; Manabu Miyata; Hiroshi Tamura; Masayuki Hata; Ayako Takahashi; Masahiro Miyake; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):OD85.

ARVO Imaging in the Eye Conference Abstract June 2023

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Antonio MARCELO BARBANTE Casella; Raphaela M Fuganti; Luiz Lima; Ahmad Mansour; Michel Farah; Mauricio Maia; Luis Roisman; Francisco Rodriguez; Juliana Prazeres; Jose Ignacio Fernández-Vigo; Suthasinee Sinawat; Jay Chhablani; Lorenzo López-Guajard; Igor Kozak; A Osman Saatci; Stephen Schwartz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0044.

ARVO Annual Meeting Abstract June 2023

Real-time temperature-guided laser therapy in central serous chorioretinopathy

Claus von der Burchard; Veit Danicke; Christopher Kren; Jan-Erik Fleger; Sebastian Wittmeier; Dirk Theisen-Kunde; Ralf Brinkmann; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1806.

ARVO Annual Meeting Abstract June 2023

Long-term analysis of selective retina therapy effect in patients with chronic central serous chorioretinopathy

Migle Lindziute; Maximilian Binter; Nizar Al Mahamed; Amelie Pielen; Carsten Framme; Jan Tode

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1800.

ARVO Annual Meeting Abstract June 2023

Comparison of fundus autofluorescence findings with a genetic predisposition in central serous chorioretinopathy

norihiko misawa; akika kyo; kumiko hirayama; Manabu Yamamoto; Takeya Kohno; shigeru honda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2758.

ARVO Annual Meeting Abstract June 2023

Multifocal electroretinography changes over 12 months after resolution of central serous chorioretinopathy: prospective observational study

In Hwan Hong; Bo Hee Kim; Gang Seok Jeon; In Boem Chang

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2746.

ARVO Annual Meeting Abstract June 2023

Imaging characteristics and clinical outcomes of pigment epithelial detachments associated with central serous chorioretinopathy at three-year follow-up

Arman Zarnegar; Selina Chang; Razeen Khan; Joshua Ong; Amrish Selvam; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3420.

ARVO Annual Meeting Abstract June 2023

Deep Learning-Based Choroidal Volumetric Analysis After Photodynamic Therapy or Focal Laser For Central Serous Chorioretinopathy

Kazuichi Maruyama; Chikako Hara; Taku Wakabayashi; Zaixing Mao; Ryo Kawasaki; Shiyi Liu; Zhenguo Wang; Kinpui Chan; Kohji Nishida

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3366.

ARVO Annual Meeting Abstract June 2023

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

Sekar Galuh; Elon van Dijk; Esmeralda K. Bosma; Joost Brinks; Reinier O. Schlingemann; Ingeborg Klaassen; Onno C. Meijer; Camiel J.F. Boon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3008.

ARVO Annual Meeting Abstract June 2023

Selective Retina Therapy with Real-Time Feedback technology in Central Serous Chorioretinopathy (CSC): a 24-month follow-up prospective single-arm clinical trial

Hyeong Gon Yu; Chang Ki Yoon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3751.

ARVO Annual Meeting Abstract June 2023

Comparing treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses

Eunice You; Mélanie Hébert; Tony Shicheng Jin; Serge Bourgault; Mathieu Caissie; Éric Tourville; John Chen; José Ordoñez-Ména; Ali Dirani

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3750.

ARVO Annual Meeting Abstract June 2023

Long term follow-up of photodynamic therapy treatment for central serous chorioretinopathy

Chiara M Eandi; Eleonora Riotto

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3720.

ARVO Annual Meeting Abstract June 2023

Characteristics associated with visual acuity loss after photodynamic therapy for central serous chorioretinopathy

Ryoh Funatsu; Hiroto Terasaki; Shozo Sonoda; hideki shiihara; Naohisa Mihara; Taiji Sakamoto

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3669.

ARVO Annual Meeting Abstract June 2023

Features of venous overload in central serous chorioretinopathy

Laurenz J. B. Pauleikhoff; Rosalie Diederen; Elon Van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3656.

ARVO Annual Meeting Abstract June 2023

Long-term visual outcomes of photodynamic therapy in patients with central serous chorioretinopathy

Romy Bejjani; Panisa Singhanetr; Elizabeth Rossin; Demetrios G. Vavvas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3650.

ARVO Annual Meeting Abstract June 2023

Compositional and functional features of the gut microbiome in patients with acute onset central serous chorioretinopathy

Martin Sebastian Zinkernagel; Liselotte Berger; Elio Luca Herzog; Sebastian Wolf; Denise Zysset

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3582.

ARVO Annual Meeting Abstract June 2023

Choroidal Thickness Differences Between Genders with Central Serous Chorioretinopathy

Priya Pragnesh Shah; Elizabeth Rossin

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4185.

ARVO Annual Meeting Abstract June 2023

Characterising central serous chorioretinopathy and choroidal thickness in UK Biobank

Catherine Jamison; Barbra Hamill; Michael J Quinn; Alyson Muldrew; Alan Sproule; Peter Blows; Savita Madhusudhan; Konstantinos Balaskas; Andrew J Lotery; Tunde Peto; Paul Foster

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4184.

ARVO Annual Meeting Abstract June 2023

Immune checkpoint inhibitor-induced acute posterior placoid pigment epitheliopathy-like chorioretinopathy

Jeffrey Yu; Lesley Everett; Therese Sassalos; Mark W Johnson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3703.

1 2 3 4 5

Next 20 Results »

Search Results for Chorioretinopathy

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Choroidal Vortex Vein Drainage System in Central Serous Chorioretinopathy Using Ultra-Widefield Optical Coherence Tomography Angiography

Choroidal Angiographic Feature Associated with Persistent Subretinal Fluid in Central Serous Chorioretinopathy

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Real-time temperature-guided laser therapy in central serous chorioretinopathy

Long-term analysis of selective retina therapy effect in patients with chronic central serous chorioretinopathy

Comparison of fundus autofluorescence findings with a genetic predisposition in central serous chorioretinopathy

Multifocal electroretinography changes over 12 months after resolution of central serous chorioretinopathy: prospective observational study

Imaging characteristics and clinical outcomes of pigment epithelial detachments associated with central serous chorioretinopathy at three-year follow-up

Deep Learning-Based Choroidal Volumetric Analysis After Photodynamic Therapy or Focal Laser For Central Serous Chorioretinopathy

Cortisol-modulated Barrier Properties of Cultured Choroidal Endothelial Cells: a Model to Study Central Serous Chorioretinopathy

Selective Retina Therapy with Real-Time Feedback technology in Central Serous Chorioretinopathy (CSC): a 24-month follow-up prospective single-arm clinical trial

Comparing treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses

Long term follow-up of photodynamic therapy treatment for central serous chorioretinopathy

Characteristics associated with visual acuity loss after photodynamic therapy for central serous chorioretinopathy

Features of venous overload in central serous chorioretinopathy

Long-term visual outcomes of photodynamic therapy in patients with central serous chorioretinopathy

Compositional and functional features of the gut microbiome in patients with acute onset central serous chorioretinopathy

Choroidal Thickness Differences Between Genders with Central Serous Chorioretinopathy

Characterising central serous chorioretinopathy and choroidal thickness in UK Biobank

Immune checkpoint inhibitor-induced acute posterior placoid pigment epitheliopathy-like chorioretinopathy

Search Results for Chorioretinopathy

To View More...

You must be signed into an individual account to use this feature.